FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GRAY MARY ANN

 2. Date of Event Requiring Statement (MM/DD/YYYY)
7/19/2019 

 3. Issuer Name and Ticker or Trading Symbol

Neuralstem, Inc. [CUR]

(Last)        (First)        (Middle)

20271 GOLDENROD LANE, 2ND FLOOR

 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)

(Street)

GERMANTOWN, MD 20876      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock (1)7355 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Purchase Option (2)7/19/2019 7/1/2029 Common Stock 4954 (2)$5.90 D  
Restricted Stock Units (3)7/19/2019 (4) (4)Common Stock 4904 (4) (3)D  
Explanation of Responses:
(1) The shares represented are restricted stock grants pursuant to 45% of compensatory Annual Grant for director services equal to $100,000. The shares vest quarterly on 9/30/19, 12/31/19, 3/31/,20 and 6/30/20.
(2) Represents 25% of compensatory Annual Grant for director services equal to $100,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.
(3) Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
(4) Represents 30% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
GRAY MARY ANN
20271 GOLDENROD LANE, 2ND FLOOR
GERMANTOWN, MD 20876		X
Signatures
/s/ Mary Ann Gray10/11/2019
**Signature of Reporting PersonDate
Neuralstem (NASDAQ:CUR)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025 Haga Click aquí para más Gráficas Neuralstem.
Neuralstem (NASDAQ:CUR)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025 Haga Click aquí para más Gráficas Neuralstem.